Easywell Biomedicals Profit Margin

Easywell Biomedicals (1799.TWO) currently reports a profit margin of -2.03% as of June 2026. That compares with -12.72% in the prior-year period — up 84.0% year over year. That is below the sector sector average of 13.16%. Use the charts on this page to explore Easywell Biomedicals's profit margin history and peer comparisons.

Easywell Biomedicals's profit margin increased from -12.72% to -2.03% — a 84.0% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Easywell Biomedicals's profit margin of -2.03% is lower than the its sector sector average of 13.16%. That is roughly 115.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Easywell Biomedicals's current -2.03% should be judged against industry norms (sector average: 13.16%) and against 1799.TWO's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -2.03%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.16%. From there, open related valuation or income-statement pages for Easywell Biomedicals, and consider following 1799.TWO for alerts when major investors trade the stock.